What is Halley E Gilbert's role at Neogenomics Inc?

Halley E Gilbert reports to the SEC as officer at Neogenomics Inc (NEO), according to the latest filing on March 4, 2022. Halley E Gilbert has also filed as director at CytomX Therapeutics, Inc. (CTMX), director at Vaxcyte, Inc. (PCVX) and director at Arcutis Biotherapeutics, Inc. (ARQT).

How many shares does Halley E Gilbert own?

After the latest filing that states it, Halley E Gilbert directly owned 12,481 shares of Vaxcyte, Inc. (PCVX), 27,901 shares of Arcutis Biotherapeutics, Inc. (ARQT) and 147,396 shares of Neogenomics Inc (NEO). Shares held through trusts, funds or family members are reported separately and are not counted here.

Has Halley E Gilbert bought or sold stock recently?

The most recent open-market sale was on November 20, 2025: sold 16,532 shares of Arcutis Biotherapeutics, Inc. (ARQT) for $455K at an average of $27.55.

How do I get alerts when Halley E Gilbert files?

Follow Halley E Gilbert on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

Insiders · NEO

Halley E Gilbert

Officer at Neogenomics Inc (NEO) since August 2021

Halley E Gilbert has filed 27 insider reports with the SEC since June 2021, as director at CytomX Therapeutics, Inc. (CTMX), director at Vaxcyte, Inc. (PCVX) and director at Arcutis Biotherapeutics, Inc. (ARQT) and at 1 more company. In the last 12 months Halley E Gilbert sold $455K of stock on the open market. The latest filing, on June 22, 2026, reports grant or award at CytomX Therapeutics, Inc. (CTMX).

Filings: 27
Companies: 4
Bought on market: None
Sold on market: $1.78M

Companies where Halley E Gilbert is an insider

Company	Role	Shares held	Sold	Price now	Last filing
CTMX CytomX Therapeutics, Inc.	Director			$2.13	Jun 22, 2026
PCVX Vaxcyte, Inc.	Director	12,481	$1.33M	$68.62	Jun 16, 2026
ARQT Arcutis Biotherapeutics, Inc.	Director	27,901	$455K	$28.38	Jun 10, 2026
NEO Neogenomics Inc	Officersince August 2021	147,396		$16.83	Mar 4, 2022

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Also sits on boards with

Officers and directors who share two or more companies with Halley E Gilbert.

Compare Halley E Gilbert with

Other insiders at the same companies

Questions about Halley E Gilbert

What is Halley E Gilbert's role at Neogenomics Inc?: Halley E Gilbert reports to the SEC as officer at Neogenomics Inc (NEO), according to the latest filing on March 4, 2022. Halley E Gilbert has also filed as director at CytomX Therapeutics, Inc. (CTMX), director at Vaxcyte, Inc. (PCVX) and director at Arcutis Biotherapeutics, Inc. (ARQT).
How many shares does Halley E Gilbert own?: After the latest filing that states it, Halley E Gilbert directly owned 12,481 shares of Vaxcyte, Inc. (PCVX), 27,901 shares of Arcutis Biotherapeutics, Inc. (ARQT) and 147,396 shares of Neogenomics Inc (NEO). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Halley E Gilbert bought or sold stock recently?: The most recent open-market sale was on November 20, 2025: sold 16,532 shares of Arcutis Biotherapeutics, Inc. (ARQT) for $455K at an average of $27.55.
How do I get alerts when Halley E Gilbert files?: Follow Halley E Gilbert on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Halley E Gilbert (SEC CIK 0001601360). Totals count each trade once, skipping amendments whose original is on file, from Jun 3, 2021 on. View on SEC EDGAR